Longest Clinical Study of Smegglutide Published: Continuous Four Years of Medication Can Maintain 10% Weight Loss
JESUS60
发表于 2024-5-14 17:49:02
1242
0
0
[The longest clinical study of Smeglutide was published: it can maintain a weight loss of 10% after four years of medication] Star weight loss therapy Smeglutide manufacturer Novo Nordisk displayed the longest clinical follow-up data of the company so far at the European Obesity Conference on May 14, local time. The results showed that overweight and obese patients with heart disease but no diabetes could still maintain an average weight loss of 10% after four years of continuous treatment with Wegovy, a weight loss drug of Smeglutide.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Can Smegglutide Help Quit Alcohol? Novo Nordisk's latest liver disease research will provide answers
- AstraZeneca: Clinical studies have shown that targeted anti-cancer drug Teresa can prolong progression free survival by more than 3 years
- Novo Nordisk responds that semaglutide may cause male impotence
- How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
- Will Smegglutide's indications for treating obesity participate in this year's national medical insurance negotiations? Novo Nordisk responded by stating that they will immediately initiate internet access and hospital admissions in various regions
- Will the reduced weight version of Smegglutide be limited in supply to the Chinese market? Novo Nordisk responds
- The Battle of Weight Loss Drugs Begins: Smegglutide's Obesity Indications Approved in China
- After nearly four years, Ping An of China has passively consolidated its holdings in Lufax, with a shareholding ratio expected to increase to 56.82%, stating that it has no intention of privatization
- Zaiding Medicine: Clinical study of KarXT for the treatment of schizophrenia completed, enrolled patients from mainland China
- Poor performance, Nike changes leadership: retired veteran of four years appointed as new CEO
-
每经AI快讯,据亿航智能官微消息,公司EH216-S无人驾驶电动垂直起降航空器(eVTOL)获得巴西国家民航局颁发的试验飞行许可证书,并计划在巴西进行测试和试飞。关于EH216-S无人驾驶eVTOL在巴西的认证,中国民航局 ...
- 潇湘才子
- 11 小时前
- 支持
- 反对
- 回复
- 收藏
-
今年7月,美国三大海外“债主”所持美国国债齐刷刷缩水,其中日本美债持仓已降至去年10月以来最低。 根据美国财政部当地时间9月18日公布的国际资本流动报告(TIC),2024年7月,美国前三大海外“债主”日本 ...
- 520hacker
- 前天 20:44
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者俞立严)9月19日,蔚来全新品牌乐道的首款车型——乐道L60正式上市。新车定位家庭智能电动SUV,在采用BaaS电池租用服务后,L60的售价可低至14.99万元,电池租用月费最低为599元。乐道L6 ...
- anhao007
- 昨天 11:03
- 支持
- 反对
- 回复
- 收藏
-
每经记者袁园 日前,国务院印发的《关于加强监管防范风险推动保险业高质量发展的若干意见》提出,以新能源汽车商业保险为重点,深化车险综合改革。 “车险综改”从2015年就已经开始逐步推进了,经过 ...
- moshulong
- 昨天 21:50
- 支持
- 反对
- 回复
- 收藏